Pieris Pharmaceuticals CEO Stephen Yoder's 2023 pay falls 34% to $1.4M
Pieris Pharmaceuticals reports 2023 executive compensation
By ExecPay News
Published: November 6, 2024
Pieris Pharmaceuticals reported fiscal year 2023 executive compensation information on November 6, 2024.
In 2023, three executives at Pieris Pharmaceuticals received on average a compensation package of $931K, a 38% decrease compared to previous year.
Average pay of disclosed executives at Pieris Pharmaceuticals
Stephen S. Yoder, Chief Executive Officer, received $1.4M in total, which decreased by 34% compared to 2022. 45% of Yoder's compensation, or $615K, was in option awards. Yoder also received $146K in bonus, $585K in salary, as well as $13K in other compensation.
Thomas Bures, Chief Financial Officer, received a compensation package of $729K, which decreased by 23% compared to previous year. 55% of the compensation package, or $400K, was in salary.
Shane Olwill, Former Senior Vice President and Chief Development Officer, earned $705K in 2023.
Related executives
You may also like
Source: SEC filing on November 6, 2024.